Fox Foundation offers $2m for ‘game-changing’ Parkinson’s breakthrough

PD in Practice

Author: Parkinson's Life editorsPublished: 7 July 2016

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

MJFF $2 grant

The Michael J Fox Foundation is offering US$2 million to the first researcher to develop a tracer for alpha-synuclein – the protein that is a strong pathological indicator of Parkinson’s disease.

Imaging of alpha-synuclein could become a useful biomarker of the presence of the disease and possibly even a measure of disease progression.

In a statement issued on its website, the Foundation said: “The ability to image alpha-synuclein deposition in the brain would be a game-changing achievement for the Parkinson’s disease field.

“With this prize, the Foundation seeks to attract research teams and accelerate momentum to speed the development of such a tracer.”

The prize is open to all academic and industry researchers and contestants may already be funded by the MJFF or not. There is no deadline and the $2 million prize will be awarded to the first contestant who submits “compelling evidence of a viable selective tracer and agrees to its widespread use”.


To see the full submission requirements, the judging panel and how to apply, visit the website here

Learn more about alpha-synuclein in this free podcast: ‘Stopping disease progression’

Go Back

Share this story

Comments


Related articles


Avocado pear

Recipes & Nutrition

Naturally good food: the diets proven to boost the body against Parkinson’s

Diets from around the world that help Parkinson’s symptoms

READ MORE
EPDA Toolkits lead

Resources & Tools

6 free guides to help raise awareness of Parkinson’s disease

Parkinson’s toolkits: practical guides for patient organisations

READ MORE
100 For Parkinson's lead

Special reports

High blood pressure, arthritis and depression are most common conditions in Parkinson’s patients

“We cannot gather too much data”

READ MORE